N. Pereverzina
*, A. Allenova
*, E. Gribaleva
, D. Munblit
, D. Skander
, P. Kolkhir
1Department of Central State Medical Academy of the Administrative of the President of Russia, Department of Dermatology and Cosmetology, Moscow, Russia
2Laboratory of Immune-Mediated Skin Diseases, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
3Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
4Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, U.K.
5Research and Clinical Center for Neuropsychiatry, Moscow, Russia
6 Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany
*These authors contributed equally to this work
HistoryPublished: 20 July 2021
Accepted: 20 July 2021
Received: 15 April 2021
Chronic spontaneous urticaria; coronavirus; SARS-CoV-2; COVID-19; restrictions; telemedicine; digital medicine service; pandemic impact.